Iversen L, Deleuran B, Hoberg A M, Kragballe K
Department of Dermatology, Marselisborg Hospital, University of Aarhus, Denmark.
Arch Dermatol Res. 1996 May;288(5-6):217-24. doi: 10.1007/BF02530088.
Leukotriene A4 (LTA4) hydrolase which transforms LTA4 into the proinflammatory compound LTB4 has been identified in human epidermis. The purpose of this study was to investigate the potential role of this enzyme in psoriasis, in which LTB4 is present in biologically active concentrations. The concentration and activity of LTA4 hydrolase was determined in normal skin and in matched samples of involved and uninvolved psoriatic skin. The enzyme content was determined using an affinity-purified antibody. This antibody was also used for immunohistochemical staining of skin biopsies. Immunohistochemically LTA4 hydrolase was localized predominantly in the basal and spinous layers in normal skin and in involved and uninvolved psoriatic skin. The LTA4 hydrolase content varied between 2.8 and 3.1 micrograms enzyme/mg protein and was found to be similar in normal and psoriatic skin, involved as well as uninvolved. In contrast, the activity of the enzyme was decreased significantly in involved psoriatic skin (9.9 +/- 2.1 micrograms LTB4/mg enzyme per min) compared with matched uninvolved psoriatic skin (16.4 +/- 3.5 micrograms LTB4/mg enzyme per min), but was decreased only insignificantly compared with normal skin (12.4 +/- 1.8 micrograms LTB4/mg enzyme per min). It was found that the conversion of LTA4 to LTB4 results in inactivation of LTA4 hydrolase activity. This finding is compatible with the idea that the decreased LTA4 hydrolase activity in involved psoriatic skin reflects transcellular LTB4 formation in vivo. In peripheral lymphocytes the enzyme content was 1.3 +/- 0.3 microgram enzyme/mg protein in normal lymphocytes and 1.4 +/- 0.3 microgram enzyme/mg protein in psoriatic lymphocytes, which was significantly lower than in the skin. In contrast, the specific LTA4 hydrolase activities in normal and psoriatic lymphocytes (23.4 +/- 1.3 and 21.3 +/- 1.7 micrograms LTB4/mg enzyme per min) were significantly higher than in normal skin. These findings may indicate the existence of LTA4 hydrolase isoforms in human lymphocytes and human skin.
已在人表皮中鉴定出可将白三烯A4(LTA4)转化为促炎化合物白三烯B4(LTB4)的LTA4水解酶。本研究的目的是调查该酶在银屑病中的潜在作用,银屑病中LTB4以生物活性浓度存在。测定了正常皮肤以及银屑病患部和非患部匹配样本中LTA4水解酶的浓度和活性。使用亲和纯化抗体测定酶含量。该抗体还用于皮肤活检组织的免疫组织化学染色。免疫组织化学显示,LTA4水解酶主要定位于正常皮肤以及银屑病患部和非患部皮肤的基底层和棘层。LTA4水解酶含量在2.8至3.1微克酶/毫克蛋白质之间,在正常皮肤和银屑病皮肤(患部和非患部)中相似。相比之下,与匹配的银屑病非患部皮肤(16.4±3.5微克LTB4/毫克酶每分钟)相比,银屑病患部皮肤中该酶的活性显著降低(9.9±2.1微克LTB4/毫克酶每分钟),但与正常皮肤(12.4±1.8微克LTB4/毫克酶每分钟)相比仅略有降低。发现LTA4向LTB4的转化导致LTA4水解酶活性失活。这一发现与以下观点相符,即银屑病患部皮肤中LTA4水解酶活性降低反映了体内跨细胞LTB4的形成。在周围淋巴细胞中,正常淋巴细胞的酶含量为1.3±0.3微克酶/毫克蛋白质,银屑病淋巴细胞的酶含量为1.4±0.3微克酶/毫克蛋白质,均显著低于皮肤中的含量。相比之下,正常和银屑病淋巴细胞中的特异性LTA4水解酶活性(23.4±1.3和21.3±1.7微克LTB4/毫克酶每分钟)显著高于正常皮肤。这些发现可能表明人淋巴细胞和人皮肤中存在LTA4水解酶同工型。